Cantor Fitzgerald adjusted its price target for Teradyne stock (NASDAQ:TER), bringing it down to $150 from the previous $160, while still maintaining an Overweight rating on the company's shares.
This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...
Each year, Cantor Fitzgerald and BGC donate 100 percent of their global ... Mariano Rivera, Willie Randolph, Dwight Doc Gooden, Olympic gold medallist winners Bode Miller and Mikaela Shiffrin and ...
Cantor Fitzgerald upgraded Lam Research (LRCX) to Overweight from Neutral with a price target of $100, up from $95. The firm had suggested ...
Investment firm Cantor Fitzgerald recently penned a research ... Shares were likely range-bound into DOC/BIS announcement, ...
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for shares of Crinetics Pharmaceuticals ...
Cantor Fitzgerald raised the firm’s price target on CyberArk (CYBR) to $415 from $335 and keeps an Overweight rating on the shares. The firm is bullish on the Venafi opportunity, and thinks the ...